Drugs / IL-YANG Inactivated Split Influenza Vaccine
IL-YANG Inactivated Split Influenza Vaccine
also known as
IL-YANG FLU Vaccine Prefilled Syringe INJ.
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02330003 | May → Aug 2013 | — | Il-Yang Pharm. Co., Ltd. | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT02154308 | Nov 2012 → Mar 2013 | — | Il-Yang Pharm. Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IL-YANG Inactivated Split Influenza Vaccine | “IL-YANG Inactivated Split Influenza Vaccine in Healthy Adults 18 to < 65 Years of Age and in Healthy Adults ≥ 65 Years of Age.” NCT02154308 ↗1“IL-YANG Inactivated Split Influenza Vaccine (IL-YANG FLU Vaccine Prefilled Syringe INJ.)” NCT02330003 ↗ |
| Known as | IL-YANG FLU Vaccine Prefilled Syringe INJ. | “IL-YANG Inactivated Split Influenza Vaccine (IL-YANG FLU Vaccine Prefilled Syringe INJ.)” NCT02330003 ↗ |
| Modality | Vaccine | “Inactivated Split Influenza Vaccine” NCT02154308 ↗ |
| Route | Intramuscular | “single-dose intramuscular administration” NCT02330003 ↗ |